Physician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment

Tomohiro Iida,1 Keirei Ishii2 1Department of Ophthalmology, Tokyo Women’s Medical University, Tokyo, 2Health Economics and Outcomes Research, Bayer Yakuhin Ltd., Osaka, Japan Purpose: The purpose of this study was to monitor anti-vascular endothelial growth factor (anti-VEGF) tr...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Iida T, Ishii K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	wet age-related macular degeneration anti-vascular growth factor anti-VEGF as-needed anti-VEGF treat-and-extend wAMD patient experience Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/ed93e2d55e3748ca8d0f4ada973f89e0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ed93e2d55e3748ca8d0f4ada973f89e0
record_format	dspace
spelling	oai:doaj.org-article:ed93e2d55e3748ca8d0f4ada973f89e02021-12-02T05:55:07ZPhysician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment1177-5483https://doaj.org/article/ed93e2d55e3748ca8d0f4ada973f89e02016-12-01T00:00:00Zhttps://www.dovepress.com/physician-patient-and-caregiver-experience-of-different-wet-age-relate-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Tomohiro Iida,1 Keirei Ishii2 1Department of Ophthalmology, Tokyo Women’s Medical University, Tokyo, 2Health Economics and Outcomes Research, Bayer Yakuhin Ltd., Osaka, Japan Purpose: The purpose of this study was to monitor anti-vascular endothelial growth factor (anti-VEGF) treatment regimens for wet age-related macular degeneration (wAMD) in clinical practice and to determine how they impact the physician, patient, and caregiver treatment experience. Materials and methods: This was a qualitative analysis based on semistructured interviews with 20 ophthalmologists who had practiced both pro re nata (PRN) and treat-and-extend (T&E) anti-VEGF regimens for wAMD. Interview questions were constructed to assess how the different regimens affected patient and caregiver experiences (in the opinion of the ophthalmologist) in addition to the ophthalmologist’s own experience. The interview included questions relating to 1) issues and benefits of PRN and T&E; 2) logistical and operational issues of introducing proactive therapy, especially T&E, to PRN practice; and 3) actions taken to handle the issues raised in 2). Results: A total of 18 interview results were eligible for analysis. The study demonstrated that the benefits of T&E compared with PRN included decreased burden of patient consultations, decreased patient and caregiver emotional burden, and a sustained period of macular dryness. The issues associated with T&E were increased number of injections and financial burden from prolonged treatment duration. The ophthalmologists also experienced difficulty explaining the significance of proactive injections to patients. Countermeasures to operational issues experienced by ophthalmologists varied by practice. Conclusion: Patients, caregivers, and the practicing ophthalmologists experienced benefits associated with a T&E regimen. However, in order to encourage better understanding of the T&E regimen, including its smooth implementation and significance for patients, a formal T&E treatment guideline providing standard practice should be considered. Keywords: wet age-related macular degeneration, anti-vascular growth factor, anti-VEGF as-needed, anti-VEGF treat-and-extend, wAMD patient experienceIida TIshii KDove Medical Pressarticlewet age-related macular degenerationanti-vascular growth factoranti-VEGF as-neededanti-VEGF treat-and-extendwAMD patient experienceOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 10, Pp 2505-2513 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	wet age-related macular degeneration anti-vascular growth factor anti-VEGF as-needed anti-VEGF treat-and-extend wAMD patient experience Ophthalmology RE1-994
spellingShingle	wet age-related macular degeneration anti-vascular growth factor anti-VEGF as-needed anti-VEGF treat-and-extend wAMD patient experience Ophthalmology RE1-994 Iida T Ishii K Physician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment
description	Tomohiro Iida,1 Keirei Ishii2 1Department of Ophthalmology, Tokyo Women’s Medical University, Tokyo, 2Health Economics and Outcomes Research, Bayer Yakuhin Ltd., Osaka, Japan Purpose: The purpose of this study was to monitor anti-vascular endothelial growth factor (anti-VEGF) treatment regimens for wet age-related macular degeneration (wAMD) in clinical practice and to determine how they impact the physician, patient, and caregiver treatment experience. Materials and methods: This was a qualitative analysis based on semistructured interviews with 20 ophthalmologists who had practiced both pro re nata (PRN) and treat-and-extend (T&E) anti-VEGF regimens for wAMD. Interview questions were constructed to assess how the different regimens affected patient and caregiver experiences (in the opinion of the ophthalmologist) in addition to the ophthalmologist’s own experience. The interview included questions relating to 1) issues and benefits of PRN and T&E; 2) logistical and operational issues of introducing proactive therapy, especially T&E, to PRN practice; and 3) actions taken to handle the issues raised in 2). Results: A total of 18 interview results were eligible for analysis. The study demonstrated that the benefits of T&E compared with PRN included decreased burden of patient consultations, decreased patient and caregiver emotional burden, and a sustained period of macular dryness. The issues associated with T&E were increased number of injections and financial burden from prolonged treatment duration. The ophthalmologists also experienced difficulty explaining the significance of proactive injections to patients. Countermeasures to operational issues experienced by ophthalmologists varied by practice. Conclusion: Patients, caregivers, and the practicing ophthalmologists experienced benefits associated with a T&E regimen. However, in order to encourage better understanding of the T&E regimen, including its smooth implementation and significance for patients, a formal T&E treatment guideline providing standard practice should be considered. Keywords: wet age-related macular degeneration, anti-vascular growth factor, anti-VEGF as-needed, anti-VEGF treat-and-extend, wAMD patient experience
format	article
author	Iida T Ishii K
author_facet	Iida T Ishii K
author_sort	Iida T
title	Physician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment
title_short	Physician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment
title_full	Physician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment
title_fullStr	Physician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment
title_full_unstemmed	Physician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment
title_sort	physician, patient, and caregiver experience of different wet age-related macular degeneration anti-vegf treatment regimens in japan: a qualitative assessment
publisher	Dove Medical Press
publishDate	2016
url	https://doaj.org/article/ed93e2d55e3748ca8d0f4ada973f89e0
work_keys_str_mv	AT iidat physicianpatientandcaregiverexperienceofdifferentwetagerelatedmaculardegenerationantivegftreatmentregimensinjapanaqualitativeassessment AT ishiik physicianpatientandcaregiverexperienceofdifferentwetagerelatedmaculardegenerationantivegftreatmentregimensinjapanaqualitativeassessment
_version_	1718400207167684608

Physician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment

Ejemplares similares